These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18559937)

  • 1. Restoration of the antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus by delivery of engineered thymidylate kinase to T cells.
    Lavie A; Su Y; Ghassemi M; Novak RM; Caffrey M; Sekulic N; Monnerjahn C; Konrad M; Cook JL
    J Gen Virol; 2008 Jul; 89(Pt 7):1672-1679. PubMed ID: 18559937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical analysis of the pharmacology of AZT and its use in AIDS.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Causer D; Alphonso H; Miller T
    Curr Med Res Opin; 1999; 15 Suppl 1():S1-45. PubMed ID: 11594171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 3'-azido group is not the primary determinant of 3'-azido-3'-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1.
    Sluis-Cremer N; Arion D; Parikh U; Koontz D; Schinazi RF; Mellors JW; Parniak MA
    J Biol Chem; 2005 Aug; 280(32):29047-52. PubMed ID: 15970587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line.
    Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase.
    Whittingham JL; Carrero-Lerida J; Brannigan JA; Ruiz-Perez LM; Silva AP; Fogg MJ; Wilkinson AJ; Gilbert IH; Wilson KS; González-Pacanowska D
    Biochem J; 2010 May; 428(3):499-509. PubMed ID: 20353400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for efficient phosphorylation of 3'-azidothymidine monophosphate by Escherichia coli thymidylate kinase.
    Lavie A; Ostermann N; Brundiers R; Goody RS; Reinstein J; Konrad M; Schlichting I
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14045-50. PubMed ID: 9826650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
    J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressing engineered thymidylate kinase variants in human cells to improve AZT phosphorylation and human immunodeficiency virus inhibition.
    Wöhrl BM; Loubière L; Brundiers R; Goody RS; Klatzmann D; Konrad M
    J Gen Virol; 2005 Mar; 86(Pt 3):757-764. PubMed ID: 15722537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.
    Brehm JH; Koontz D; Meteer JD; Pathak V; Sluis-Cremer N; Mellors JW
    J Virol; 2007 Aug; 81(15):7852-9. PubMed ID: 17507476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bottleneck in AZT activation.
    Lavie A; Schlichting I; Vetter IR; Konrad M; Reinstein J; Goody RS
    Nat Med; 1997 Aug; 3(8):922-4. PubMed ID: 9256287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and genetical analysis of AZT-resistant HIV-mutants.
    Biesert L; Zimmermann F; Schröder B; Matthes E; Suhartono H; Dietrich U; Rübsamen-Waigmann H
    Behring Inst Mitt; 1991 Jul; (89):74-80. PubMed ID: 1930105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
    Selmi B; Deval J; Alvarez K; Boretto J; Sarfati S; Guerreiro C; Canard B
    J Biol Chem; 2003 Oct; 278(42):40464-72. PubMed ID: 12902345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1.
    Borkow G; Arion D; Wainberg MA; Parniak MA
    Antimicrob Agents Chemother; 1999 Feb; 43(2):259-63. PubMed ID: 9925515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.
    Dianzani F; Antonelli G; Turriziani O; Dong G; Capobianchi MR; Riva E
    Antiviral Res; 1992 May; 18(1):39-52. PubMed ID: 1384427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2001 May; 75(10):4832-42. PubMed ID: 11312355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
    Chang S; Griesgraber GW; Southern PJ; Wagner CR
    J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.